APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 42 filers reported holding APPLIED GENETIC TECHNOL CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,000 | -16.7% | 1,200 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -89.3% | 1,200 | -85.3% | 0.00% | – |
| Q1 2017 | $56,000 | -36.4% | 8,163 | -13.0% | 0.00% | – |
| Q4 2016 | $88,000 | +10.0% | 9,387 | +14.7% | 0.00% | – |
| Q3 2016 | $80,000 | -43.3% | 8,187 | -18.0% | 0.00% | -100.0% |
| Q2 2016 | $141,000 | +28.2% | 9,987 | +27.3% | 0.00% | – |
| Q1 2016 | $110,000 | -27.6% | 7,848 | +5.2% | 0.00% | -100.0% |
| Q4 2015 | $152,000 | +55.1% | 7,463 | 0.0% | 0.00% | – |
| Q3 2015 | $98,000 | -19.0% | 7,463 | -5.1% | 0.00% | – |
| Q2 2015 | $121,000 | -26.2% | 7,863 | -4.4% | 0.00% | -100.0% |
| Q1 2015 | $164,000 | -16.8% | 8,227 | -12.1% | 0.00% | 0.0% |
| Q4 2014 | $197,000 | -49.5% | 9,362 | -55.3% | 0.00% | -50.0% |
| Q3 2014 | $390,000 | +84.0% | 20,955 | +128.8% | 0.00% | +100.0% |
| Q2 2014 | $212,000 | – | 9,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,404,515 | $1,081,000 | 2.01% |
| SABBY MANAGEMENT, LLC | 811,973 | $625,000 | 0.42% |
| Portolan Capital Management | 1,605,599 | $1,236,000 | 0.12% |
| Knoll Capital Management, LLC | 100,000 | $77,000 | 0.04% |
| Shay Capital LLC | 50,000 | $39,000 | 0.01% |
| COLONY GROUP LLC | 330,287 | $254,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 155,375 | $120,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,499,124 | $1,154,000 | 0.00% |
| Virtu Financial LLC | 10,807 | $8,000 | 0.00% |
| FIDUCIARY TRUST CO | 40,000 | $31,000 | 0.00% |